It can be a diagnostic challenge to identify COVID-19 patients in whom antibiotics can be safely withheld. We evaluate the effectiveness of a guideline implemented at Sheffield Teaching Hospitals NHS Foundation Trust that recommends withholding antibiotics in patients with a low serum procalcitonin (PCT), defined as ≤0.25ng/ml. Results showed reduced antibiotic consumption in this patient group, without increase in mortality, alongside a reduction in subsequent carbapenem prescriptions during admission for those with a negative PCT. Our results suggest effectiveness of this guideline, and further research is recommended to identify the optimal cut-off value for procalcitonin in this setting
In critically ill patients, length of antibiotic treatment can be effectively guided by procalcitoni...
Background Lower respiratory tract infections are often treated with antibiotics without evidence of...
Antibiotic stewardship during the COVID-19 pandemic is an important part of a comprehensive strategy...
It can be a diagnostic challenge to identify COVID-19 patients in whom antibiotics can be safely wit...
Antibacterial prescribing in patients presenting with COVID-19 remains discordant to rates of bacter...
We report an evaluation of the utility of serum procalcitonin (PCT) measurement as an additional dia...
Procalcitonin is a surrogate biomarker for estimating the likelihood of a bacterial infection. Proca...
The use of procalcitonin (PCT) as a tool to assist clinicians in using antibiotics in intensive care...
AbstractRecent studies have suggested that procalcitonin (PCT) is a safe marker for the discriminati...
AbstractThe serum procalcitonin (PCT) concentration reflects both the systemic response to bacterial...
Procalcitonin (PCT)-guided antibiotic stewardship (ABS) has been shown to reduce antibiotics (ABxs),...
peer reviewedDue to overlap of clinical findings and low sensitivity of bacterial diagnostic tests, ...
Procalcitonin (PCT) is a useful biomarker of bacterial infection and its use is associated to reduce...
BACKGROUND: Lower respiratory tract infections are often treated with antibiotics without evidence o...
This review aims to provide physicians with an overview of the potential of procalcitonin to guide a...
In critically ill patients, length of antibiotic treatment can be effectively guided by procalcitoni...
Background Lower respiratory tract infections are often treated with antibiotics without evidence of...
Antibiotic stewardship during the COVID-19 pandemic is an important part of a comprehensive strategy...
It can be a diagnostic challenge to identify COVID-19 patients in whom antibiotics can be safely wit...
Antibacterial prescribing in patients presenting with COVID-19 remains discordant to rates of bacter...
We report an evaluation of the utility of serum procalcitonin (PCT) measurement as an additional dia...
Procalcitonin is a surrogate biomarker for estimating the likelihood of a bacterial infection. Proca...
The use of procalcitonin (PCT) as a tool to assist clinicians in using antibiotics in intensive care...
AbstractRecent studies have suggested that procalcitonin (PCT) is a safe marker for the discriminati...
AbstractThe serum procalcitonin (PCT) concentration reflects both the systemic response to bacterial...
Procalcitonin (PCT)-guided antibiotic stewardship (ABS) has been shown to reduce antibiotics (ABxs),...
peer reviewedDue to overlap of clinical findings and low sensitivity of bacterial diagnostic tests, ...
Procalcitonin (PCT) is a useful biomarker of bacterial infection and its use is associated to reduce...
BACKGROUND: Lower respiratory tract infections are often treated with antibiotics without evidence o...
This review aims to provide physicians with an overview of the potential of procalcitonin to guide a...
In critically ill patients, length of antibiotic treatment can be effectively guided by procalcitoni...
Background Lower respiratory tract infections are often treated with antibiotics without evidence of...
Antibiotic stewardship during the COVID-19 pandemic is an important part of a comprehensive strategy...